Zebra Technologies’ foray into warehouse automation will be short lived. The enterprise technology company known mostly for its barcode scanners, RFID solutions and mobile handheld devices is exploring strategic alternatives for its robotics automation business. More from Sourcing Journal In a Monday regulatory filing with the U.S. Securities and Exchange Commission, Zebra indicated that it would “dispose [of] or exit” its autonomous mobile robotics (AMR) business. The Robot Report first broke the news o ...

Core Insights - Sales of previously occupied U.S. homes increased by 0.5% in November compared to October, reaching a seasonally adjusted annual rate of 4.13 million units, despite a year-over-year decline for the first time since May [1] - Year-over-year sales fell by 1% compared to November of the previous year, slightly below the expected pace of 4.14 million units [2] - The national median sales price rose by 1.2% year-over-year to $409,200, marking 29 consecutive months of annual price increases, despite a sluggish housing market that began in 2022 [3] - Home sales have remained around a 4-million annual pace in 2023, significantly lower than the historical norm of 5.2 million annual sales [4]

Core Insights - Chipotle Mexican Grill is a pioneer in the fast-casual restaurant industry, inspiring similar business models across various cuisines [1] - Despite its strong market position, Chipotle's stock has significantly underperformed, dropping 38% in 2025, raising concerns about its business performance [3][4] - The company has downgraded its same-store sales growth forecast from low to mid-single digits to a decline in low single digits, indicating weaker financial performance [4] Financial Performance - Chipotle shares surged 368% in the five years leading up to their peak in June 2024, but faced a drastic decline in 2025 [3] - Transaction counts decreased by 0.8% in Q3 2025, with younger and lower-income demographics ordering less frequently [5] Market Conditions - The U.S. economy is not officially in a recession, but consumer spending is down due to rising costs, impacting dining out habits [6] - Management plans to continue aggressive new store openings despite the current stock decline, which is at a five-year low [6] Strategic Focus - The company aims to maintain its competitive edge through menu innovation, enhancing digital capabilities, and ensuring food quality [7]

The U.S. Federal Reserve announced Friday it was seeking feedback on establishing limited "payment accounts" for some financial firms, that would grant access to Fed payments services for clearing and settling payments, but without the broader set of benefits currently provided to banks. ...

Group 1 - Iberdrola has signed an agreement to acquire full ownership of the Ararat wind farm in Victoria, Australia, which has an installed capacity of 242MW and has been operational since 2017 [1][2] - The wind farm's electricity is primarily sold under power purchase agreements (PPAs) with major customers, ensuring stable revenue streams [1] - The acquisition aligns with Iberdrola's strategic plan for 2025-28, which includes over €1bn ($1.17bn) of planned investment in Australia [3] Group 2 - The Ararat wind farm is expected to benefit from rising electricity prices due to increasing demand for renewable energy in Victoria, where the government aims for 95% renewable energy sourcing by 2035 [2] - Upcoming transmission upgrades, such as the Western Renewable Link and Project Energy Connect, will enhance the wind farm's ability to export power [2] - This acquisition supports Iberdrola's strategy to expand its renewable energy portfolio in Australia and contributes to the country's electrification goals [3][4] Group 3 - Iberdrola's overall investment strategy includes a total of €58bn, with 85% allocated to countries with an A credit rating and favorable regulatory conditions [5] - The UK is set to receive €20bn, the US €16bn, the Iberian Peninsula €9bn, Brazil €7bn, and €5bn for other EU nations and Australia [5] - In September, Iberdrola also agreed to acquire an additional 30.29% stake in Neoenergia, a Brazilian energy distributor [5]

Core Insights - Sanmina Corporation (SANM) has launched a new factory in Houston, TX, aimed at producing high-quality energy products for the U.S. energy market, with production expected to start in 2027 [1] - The company has entered into a partnership with Koncar - Electrical Industry Inc. to co-design a custom medium-voltage transformer, enhancing its focus on energy markets [2] - Sanmina is strategically expanding into high-growth industries, particularly the energy sector, leveraging its global network and advanced electronics manufacturing expertise [3] Company Performance - Sanmina's stock has increased by 89.2% over the past year, slightly outperforming the industry growth of 86% [6] - The company operates a vertically integrated manufacturing model that reduces costs and enhances economies of scale, supporting its growth in high-demand sectors [6] - Sanmina's forward price-to-sales ratio stands at 0.55, which is below the industry average of 0.84, indicating potential undervaluation [7] Earnings Estimates - The Zacks Consensus Estimate for Sanmina's earnings for 2025 has seen upward revisions over the past 60 days, reflecting positive market sentiment [8] - The earnings estimates for Q1 and Q2 are currently at $2.15 and $2.36 respectively, with significant upward revisions of 27.22% and 38.82% over the past two months [9]

Core Insights - Novo Nordisk (NVO) has submitted a new drug application (NDA) to the FDA for CagriSema, a once-weekly injection aimed at reducing excess body weight in adults with obesity or overweight, with a review expected in 2026 [2][7] - CagriSema is a combination of cagrilintide and semaglutide, designed to suppress hunger and enhance fullness, potentially making it the first injectable therapy to combine a GLP-1 RA with an amylin analogue [3][4] - The NDA is supported by significant results from two phase III studies, REDEFINE 1 and REDEFINE 2, showing superior weight loss compared to placebo [4][9] Study Results - In the REDEFINE 1 study, CagriSema achieved an average weight loss of 22.7% compared to 2.3% with placebo, with 40.4% of patients losing 25% or more of their body weight [5][6] - The REDEFINE 2 study reported a mean weight loss of 15.7% with CagriSema versus 3.1% with placebo, with 89.7% of patients achieving at least 5% weight loss [9][10] - Overall, patients treated with CagriSema experienced a mean weight loss of 20.4% regardless of adherence, while the placebo group saw a 3% reduction [6][9] Market Context - Novo Nordisk's growth has been impacted by pricing pressures and competition from Eli Lilly's tirzepatide-based drugs, which have rapidly gained market share [11][12] - Eli Lilly's drugs generated $24.8 billion in sales in the first nine months of 2025, accounting for 54% of its total revenues [13] - To counteract competitive pressures, Novo Nordisk is diversifying its obesity portfolio and developing next-generation candidates, including oral formulations and partnerships for new treatments [14][15]

Amidst the fast-paced and highly competitive business environment of today, conducting comprehensive company analysis is essential for investors and industry enthusiasts. In this article, we will delve into an extensive industry comparison, evaluating Oracle (NYSE:ORCL) in comparison to its major competitors within the Software industry. By analyzing critical financial metrics, market position, and growth potential, our objective is to provide valuable insights for investors and offer a deeper understanding ...

Sales hit their highest level since February, after lower mortgage rates injected some fresh momentum into the long sluggish housing market. ...

Deep-pocketed investors have adopted a bearish approach towards CrowdStrike Holdings (NASDAQ:CRWD), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CRWD usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities f ...